| Date Filed | Type | Description |
| 10/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/27/2023 |
4
| Uihlein Richard E (10% Owner) has filed a Form 4 on GALECTIN THERAPEUTICS INC|
Txns:
| Exercised 1,466,204 warrants
@ $5, valued at
$7.3M
Exercised 170,000 warrants
@ $5, valued at
$850k
Exercised 200,000 warrants
@ $3, valued at
$600k
Exercised 200,000 warrants
@ $3.26, valued at
$652k
|
|
| 08/15/2023 |
4
| LEWIS JOEL (President and CEO) has filed a Form 4 on GALECTIN THERAPEUTICS INC|
Txns:
| Granted 12,042 shares
@ $1.6, valued at
$19.3k
|
|
| 07/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/03/2023 |
4
| LEWIS JOEL (President and CEO) has filed a Form 4 on GALECTIN THERAPEUTICS INC|
Txns:
| Granted 13,380 shares
@ $1.44, valued at
$19.3k
|
|
| 06/16/2023 |
4
| LEWIS JOEL (President and CEO) has filed a Form 4 on GALECTIN THERAPEUTICS INC|
Txns:
| Granted 13,196 shares
@ $1.46, valued at
$19.3k
|
|
| 06/01/2023 |
4
| LEWIS JOEL (President and CEO) has filed a Form 4 on GALECTIN THERAPEUTICS INC|
Txns:
| Granted 12,272 shares
@ $1.57, valued at
$19.3k
|
|
| 05/16/2023 |
4
| LEWIS JOEL (President and CEO) has filed a Form 4 on GALECTIN THERAPEUTICS INC|
Txns:
| Granted 11,748 shares
@ $1.64, valued at
$19.3k
|
|
| 05/09/2023 |
4
| LEWIS JOEL (President and CEO) has filed a Form 4 on GALECTIN THERAPEUTICS INC|
Txns:
| Granted 10,947 shares
@ $1.76, valued at
$19.3k
|
|
| 04/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/03/2023 |
4
| LEWIS JOEL (President and CEO) has filed a Form 4 on GALECTIN THERAPEUTICS INC|
Txns:
| Granted 9,175 shares
@ $2.1, valued at
$19.3k
|
|
| 03/16/2023 |
4
| LEWIS JOEL (President and CEO) has filed a Form 4 on GALECTIN THERAPEUTICS INC|
Txns:
| Granted 10,140 shares
@ $1.9, valued at
$19.3k
|
|
| 03/02/2023 |
4
| LEWIS JOEL (President and CEO) has filed a Form 4 on GALECTIN THERAPEUTICS INC|
Txns:
| Granted 9,308 shares
@ $2.07, valued at
$19.3k
Paid exercise price by delivering 75,529 shares
@ $2.07, valued at
$156.3k
|
|
| 02/07/2023 |
4
| LEWIS JOEL (President and CEO) has filed a Form 4 on GALECTIN THERAPEUTICS INC|
Txns:
| Granted 143,836 shares
@ $1.43, valued at
$205.7k
|
|
| 01/31/2023 |
4
| LEWIS JOEL (President and CEO) has filed a Form 4 on GALECTIN THERAPEUTICS INC|
Txns:
| Granted 15,086 shares
@ $1.16, valued at
$17.5k
|
|
| 01/30/2023 |
4
| Zordani Richard A. Jr. (Director) has filed a Form 4 on GALECTIN THERAPEUTICS INC|
Txns:
| Granted 40,000 options to buy
@ $1.11, valued at
$44.4k
|
|
| 01/30/2023 |
4
| Shlevin Harold H. (Director) has filed a Form 4 on GALECTIN THERAPEUTICS INC|
Txns:
| Granted 40,000 options to buy
@ $1.11, valued at
$44.4k
|
|
| 01/30/2023 |
4
| Schwartz Elissa J. (Director) has filed a Form 4 on GALECTIN THERAPEUTICS INC|
Txns:
| Granted 40,000 options to buy
@ $1.11, valued at
$44.4k
|
|
| 01/30/2023 |
4
| Rubin Marc (Director) has filed a Form 4 on GALECTIN THERAPEUTICS INC|
Txns:
| Granted 40,000 options to buy
@ $1.11, valued at
$44.4k
|
|
| 01/30/2023 |
4
| OMENN GILBERT S (Director) has filed a Form 4 on GALECTIN THERAPEUTICS INC|
Txns:
| Granted 40,000 options to buy
@ $1.11, valued at
$44.4k
|
|
| 01/30/2023 |
4
| FREEMAN KEVIN D (Director) has filed a Form 4 on GALECTIN THERAPEUTICS INC|
Txns:
| Granted 40,000 options to buy
@ $1.11, valued at
$44.4k
|
|
| 01/30/2023 |
4
| ELDRED KARY (Director) has filed a Form 4 on GALECTIN THERAPEUTICS INC|
Txns:
| Granted 40,000 options to buy
@ $1.11, valued at
$44.4k
|
|
| 01/30/2023 |
4
| AMELIO GILBERT F (Director) has filed a Form 4 on GALECTIN THERAPEUTICS INC|
Txns:
| Granted 40,000 options to buy
@ $1.11, valued at
$44.4k
|
|
| 01/30/2023 |
4
| CALLICUTT JACK W (CFO) has filed a Form 4 on GALECTIN THERAPEUTICS INC|
Txns:
| Granted 50,000 options to buy
@ $1.11, valued at
$55.5k
|
|
| 01/30/2023 |
4
| Boudes Pol F (Chief Medical Officer) has filed a Form 4 on GALECTIN THERAPEUTICS INC|
Txns:
| Granted 50,000 options to buy
@ $1.11, valued at
$55.5k
|
|
| 01/30/2023 |
4
| LEWIS JOEL (President and CEO) has filed a Form 4 on GALECTIN THERAPEUTICS INC|
Txns:
| Granted 70,000 options to buy
@ $1.11, valued at
$77.7k
|
|
| 01/30/2023 |
4
| CZIRR JAMES C (Director) has filed a Form 4 on GALECTIN THERAPEUTICS INC|
Txns:
| Granted 40,000 options to buy
@ $1.11, valued at
$44.4k
|
|
| 01/30/2023 |
4
| Uihlein Richard E (10% Owner) has filed a Form 4 on GALECTIN THERAPEUTICS INC|
Txns:
| Granted 36,036 shares
@ $1.11, valued at
$40k
Granted 40,000 options to buy
@ $1.11, valued at
$44.4k
|
|
| 01/26/2023 |
4
| ELDRED KARY (Director) has filed a Form 4 on GALECTIN THERAPEUTICS INC|
Txns:
| Bought 1,300 shares
@ $1.11, valued at
$1.4k
|
|
| 01/17/2023 |
4
| LEWIS JOEL (President and CEO) has filed a Form 4 on GALECTIN THERAPEUTICS INC|
Txns:
| Granted 15,351 shares
@ $1.14, valued at
$17.5k
|
|
| 01/03/2023 |
4
| LEWIS JOEL (President and CEO) has filed a Form 4 on GALECTIN THERAPEUTICS INC|
Txns:
| Granted 15,487 shares
@ $1.13, valued at
$17.5k
|
|
| 12/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|